Gefarnate

DRUG3 trials

Sponsors

Takeda, First Affiliated Hospital of Harbin Medical University

Conditions

Coronary Artery DiseaseDuodenal UlcerStomach Ulcer

Phase 2

Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia

First Affiliated Hospital of Harbin Medical UniversityCoronary Artery Disease

Start: 2019-09-01End: 2021-12-31Target: 70Updated: 2020-07-30

Phase 3

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

TerminatedNCT00762359

TakedaDuodenal Ulcer, Stomach Ulcer

Start: 2007-05-31End: 2008-11-30Updated: 2012-02-03

Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs

CompletedNCT00787254

TakedaDuodenal Ulcer, Stomach Ulcer

Start: 2007-04-30End: 2009-05-31Updated: 2012-02-03